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Summary:
In 2011, a dedicated Novalis  (Varian,  CA, USA) 6 MV linear accelerator for Stereotactic 
Radiosurgery  of  intracranial  and extracranial  targets  was introduced to  William Buckland 
Radiotherapy  Centre  (WBRC)  with  a  built-in  BrainLAB  AG  micro-multileaf  tertiary 
collimator,  namely  the  m3  mMLC  (BrainLAB,  Heimstetten,  Germany).  Stereotactic 
Radiosurgery with the m3 mMLC uses highly conformal fields of relatively small sizes and 
highly accurate dose delivery to the target as well as sparing the healthy tissue. The mMLC 
leaves give the beam, already defined by the jaws, the final shape of the radiation field. The 
whole collimation system contributes significantly to scattered radiation in the treatment field. 
In addition, another contribution to the total scattered radiation in the treatment field comes 
from within the patient. When calculating the radiation dose to be delivered to the patient, in 
terms of monitor units (MU), the treatment planning system must correct for the scattered 
radiation originating in both the collimation system and the patient.   
  
The effects of the patient and the collimation system on the dose output are quantified as 
phantom scatter factor (PSF) and collimator scatter factors (CSF) respectively. The product 
CSF x PSF is called the relative dose factor (RDF) and accounts for the total scatters. RDF is  
obtained  through  in-water  measurements  at  a  reference  depth  during  the  commissioning 
process of the treatment planning system to be used. RDFs are measured for a set of radiation 
fields  of  combined  jaws  and  m3  mMLC  fields  and  is  used  in  the  formalism  of  MU 
calculations by iPlan, the BrainSCAN treatment planning system as follows: 
MU=Prescribed Dose 
RDF x TPR x IDD x NLout x [SSDcal + dcal / SSD + d ]2
   (3)
The factors in the MU formula (3) are defined in Chapter I.
Amongst clinics around the world that use the Novalis (Varian, CA, USA), WBRC currently 
uses RDF measured during the commissioning of the Novalis system, using square m3 mMLC 
fields. These RDFs are accessed via look up tables for individual patient MU calculations. 
Therefore, the TPS MU calculation uses the RDF for the same or similar area as the clinical 
irregular field. The use of this approximation is known as the “equivalent square” method. In 
4
SRS, the actual planned clinical m3 mMLC fields are irregular and shaped by the mMLC 
leaves, and more complex than those set for the commissioning data measurements and the 
scatter contributions may be different to those for the regular fields. In this project, measured 
RDFs using a range of m3 mMLC (BrainLAB, Heimstetten,  Germany) fields  of different 
shapes and same equivalent square areas are investigated to validate this notion of equivalence 
between irregular and square fields. The range of the m3 mMLC fields includes the square 
mMLC fields. The “equivalent square” approach is therefore tested.
In addition and because RDFs are measured and defined for a set of jaws-mMLC fields, the 
variation  of  RDF with  respect  to  jaws  was  also  investigated,  and its  impact  on  the  MU 
accuracy;  in other words, for same m3 mMLC setting, different jaws openings were tested to 
notice the effects of jaws only on RDF. Thus, the measurements of RDF were performed for a 
range of jaws openings for each irregular  m3 mMLC field.  As part  of WBRC procedural 
decision in Stereotactic radiosurgery treatment planning with m3 mMLC, the jaws position are 
set to back up the mMLC leaves for the widest mMLC field in a given patient treatment plan 
and remain static, for the entire treatment planning and delivery. 
To achieve the above, measurements of RDF were performed and examined for ten irregular 
m3 mMLC fields of 12.3 x 12.3 to 51.0 x 51.0 mm2 equivalent square areas combined with 
fields set by the jaws of 2.5 x 2.5 to 9.8 x 9.8 cm2. Using the BrainSCAN TPS, iPlan, each m3 
mMLC field in the lowest range was generated under three different shapes of the same area. 
The  jaws  fields  were  then  set  from  the  Linac  console.  The  detectors  used  for  dose 
measurements  were  IC3,  IC13,  stereotactic  diode  (SFD)  and  the  PRESAGE  dosimeter. 
Calculations of RDF using iPlan were also performed and compared to each other for different 
shapes and same equivalent square of m3 mMLC fields.
In this context, the following research questions were addressed for an accurate and optimal 
RDF measurement in Stereotactic radiosurgery treatments: 
1. Is  the equivalent  square concept  a valid  concept  for considering irregular  fields  as 
being regular as long as they have equivalent areas only?
2. Should RDF from irregular m3 mMLC fields be considered in the commissioning of a 
planning system.
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3. Is it clinically safer to keep the jaws static throughout a treatment plan and delivery, or 
varying according to m3 mMLC fields? What is the impact of the jaws varying on 
RDFs?  
It was found that RDF were responsive to mMLC shapes even if the areas are the same. The 
response was different from a detector to another due to the size and type of the detector. The 
response of RDF for different mMLC shapes was also more pronounced for the smallest range 
of the fields, therefore the equivalent square concept is more valid for large mMLC fields 
rather than the smallest.
In  addition,  the  results  have  shown  that  only  for  the  smallest  mMLC  fields,  RDFs  are 
responsive to the jaws opening. As the mMLC field get larger, RDF are constant with respect 
to jaws. Consequently, it is more practical to keep the jaws at the same position during a given 
treatment plan and delivery for that range of mMLC fields. This also allows reducing part of 
the mechanical uncertainty related to the movements of the jaws in particular when dealing 
with many treatment fields.
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Stereotactic  Radiotherapy/Radiosurgery  (SRT/SRS)  is  an  advanced  and  highly  accurate 
technique of treating small lesions with a high radiation dose using an external radiation beam, 
[1].  The  word  Stereotactic  originated  from  the  Greek  words  «stereo»  meaning  three 
dimensional and «tactos» meaning touched. Stereotactic method refers to the use of precise 3-
D coordinates to localize and identify deep structures within the human body [1]. Stereotaxy is 
another terminology for Stereotactic that may be found in some references and that refers to 
destroying deep-seated brain structures located by use of the 3-D coordinates as well [24]. 
Intra-cranial  lesions were first treated using what was known as Stereotactic Neurosurgery 
until the very early 1990s [40], when Stereotactic technique went beyond treating intracranial 
lesions  and extended to treating  extracranial  lesions  known as  Stereotactic  body radiation 
therapy or SBRT; it includes Stereotactic treatments for neck, spine, lung, abdomen and pelvis 
small tumours in a very similar way to what has been successfully achieved for intra-cranial 
tumours [23]. 
Not  only the development  went  from intracranial  to  extracranial,  it  also went from rough 
geometrical beam collimation to refined micro multileaf collimator block [34]. Treatments of 
small fields have been highly facilitated by the availability of multileaf collimators [53] such 
as the Brainlab m3 mMLC. Furthermore,  Stereotactic went from frame-based to frameless 
Stereotactic and using image-guided treatment technology [34, 52]. 
Stereotactic radiosurgery delivers a single high radiation dose, of 1 to 50 Gy range [7], to the 
tumour and does not involve surgery, as the term may imply; it does not remove the tumour or 
lesion like an invasive procedure, but it distorts the DNA of the tumour cells. The cells then 
lose their ability to divide and retain fluids. As a result, the tumour shrinks at the rate of the 
normal cancer cell growth rate [34]. Stereotactic Radiotherapy refers to the ionizing radiation 
therapy using fractionated external beam dose. External beam radiation therapy is the standard 
form of  radiation  therapy;  it  delivers  radiation  from outside  the  body [1] using the same 
imaging techniques used in Stereotactic Radiosurgery as well as allowing time for the healthy 
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cells to recover. Fractionated SRT is usually prescribed and takes 18 months to two years for 
the benefit to be observed [34], that is the time taken for the tumor to shrink [34] as stated 
above.
SRT plays a central role in the treatment of most small head and neck tumors, whether benign 
or malignant; it is also continuously being improved towards conformal therapy and smaller 
number of fractions i.e. SRS when possible [36]. 
The use of SRS is increasing rapidly due to its success. The observed side effect of toxicity 
related to large dose delivered in a single fraction has led to SRT, fractionated radiotherapy 
[7].
About  50% of  the  lesions  to  be  treated  with  SRS/SRT  are  arteriovenous  malformations 
(AVMs), the rest is acoustic neuromas, meningiomas, pituitary adenomas, primary malignant 
tumours and solitary metastases; the volume of these tumours, generally, don’t exceed 35 cm3 
or  a maximum of 5 cm diameter so it is of extreme importance to accurately calculate and 
deliver the prescribed dose to the target, in particular when it is the case of SRS [40]. During 
the financial year 2011-2012 alone, WBRC treated 271 patients with combined SRS and SRT 
[43]. 
Apart from the techniques such as static beam, arc and dynamic treatment for treating brain 
abnormalities, the X-ray equipment in the field of SRS/SRT has also seen its own evolution 
on the basis  of clinical  demands.  The Cobalt-60 unit,  e.g.  Gamma-Knife (Elekta,  Atlanta, 
USA), was first used then megavoltage particle accelerators known as linear accelerator, or 
Linac,  with  nominal  energy  range  from 4  to  25  MV.  Gamma-Knife  is  a  cobalt-60  unit 
dedicated for SRS but its use has been in the wane due to its high cost. With up to 201 60Co 
sources, Gamma-Knife delivers a comparable dose to that delivered by a linear accelerator 
and is a superposition of all the beams in the small volume of the tumour [1, 55]. Radionics X-
Knife planning system was introduced to WBRC in 1996 for SRT and SRS. X-Knife uses 
heavy cylindrical  tertiary  collimators  that  give  a  circular  field  size  around  the  tumour  at 
isocentre. The field size is then trimmed with the jaws to bring it closer to the shape of the 
tumour and save some of the healthy brain. Amongst its limitations was contouring the lesion, 
in other words the CTV. The Radionics system was replaced by BrainLab in 2004. Using the 
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same linear accelerator, Varian 600C, BrainLab is one of the most recent and the very few 
treatment planning systems for small fields with a 3-D ability for conformal coverage of the 
target and sparing the healthy immediate surroundings. BrainLab uses a sophisticated micro-
multileaf  collimator  as  a  tertiary  collimator,  the  m3  mMLC  (BrainLAB,  Heimstetten, 
Germany). In 2011, WBRC commissioned a Novalis (Varian, CA, USA) linac dedicated to 
SRS/SRT and the latest version of BrainLab treatment planning system (TPS), the so called 
iPlan. This system was to be used in the present project.
For  a  treatment  using  SRS/SRT,  first,  a  diagnosis  is  achieved  and  a  radiation  dose  is 
prescribed by the radiation oncologist. A supporting head-frame during CT or MRI scans is 
used as well as a TPS. The frame is attached to the skull to ensure an absolute stability during 
the imaging process as well as localising the lesion in 3 dimensions in the CT/MR images 
[36]. With the aid of a computerised TPS, the radiation oncologist is able to contour the target 
before  the  TPS  pinpoints  the  isocentre  so  it  could  then  be  directly  irradiated  with  an 
appropriate number of beams. The tumour can also be treated from various angles for a better 
radiation dose distribution and target coverage [1]. 
The dose to be delivered during the SRS/SRT is,  particularly,  affected by the collimation 
setting and is consequently divided into primary and scattered dose (equation (1)) [1, 2, 42]:
Dose to the Target = Primary Dose + Scattered Dose       (1)
Examining  the  origins  of  the  dose  components  found  that  some  of  the  scattered  dose 
originates in the collimation system and some of it originates within the patient's tissue [1, 2, 
42]. 
As shown in Figure I.1, the radiation beam is gradually collimated through the Linac's head in 
order to meet the shape and size of the lesion to treat as well as the prescribed dose. The beam 
is first collimated by the conical primary collimator then by a set of jaws resulting in a square 
or rectangular radiation field that encompasses the lesion's area. Exiting the jaws field, the 
beam is finally collimated by the MLC leaves that automatically and conformably surrounds 
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the lesion once this latter is drawn and identified with an isocentre; this results in an irregular  
radiation field set by the MLC. 
Figure I.1: Simulated radiation beam shaping through a linac's collimation system. 
Reproduced from [49].
The radiation oncologist may add a margin around the target to allow for tumour movement or 
volume increase. In any case, the field set by the jaws must entirely cover and dominate the 
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MLC field. This results in a margin defined by both MLC and jaws edges as shown on Figure 
I.2.  The width of the margin is  irregular  due to the irregularity  of the MLC field and its 
variation is affected by the change of the jaws' field only for a given lesion. The margin width 
affects the amount of scattered radiation reaching the targeted lesion. It is also through the 
MLC-jaws margin that a dose from transmission and interleaves' leakage is received by the 
healthy tissue surrounding the lesion.
Figure I.2: An example of a beam eye view, BEV showing the radiation field first, set by the jaws then by the 
MLC leaves. Reproduced from [51]. The captions have been added.
The dose  in  monitor  units  (MU) (3)  to  be  delivered  from the  linear  accelerator  must  be 
corrected to account for the scatters originating in the collimation system as well as within the 
patient. These correction scatter factors are quantified as collimator scatter factors (CSF) and 
phantom scatter factor (PSF) respectively. The product PSF x CSF is called the relative dose 
factor, RDF, and represents the total scatter factor [1]. In some references, RDF is referred to 
as the machine's total output factor [38, 30]. 









RDF is part of the MU calculation algorithm used by iPlan TPS. The MU formalism is as 
follows according to [6]:
MU=Prescribed Dose 
RDF x TPR x IDD x NLout x [SSDcal + dcal / SSD + d ]2
      (3)    
Where, as described in the same reference [6]:
RDF is the Relative Dose Factor.
TPR is the Tissue Phantom Ratio. 
IDD is Idealized Dose Distribution in depth.
NLout is the Nominal Linac Output.  
SSD is the Source-Surface Distance of central beam.
d is the Depth point in tissue.  
dcal is the Depth of point where NLOut and scatter factors were measured.
RDF is  a  quantity  measured  in  water  at  a  reference  depth  as  part  of  commissioning  the 
treatment planning system used in SRS/SRT; the measurement of RDF is performed for a 
number of fields and extrapolation is used to non-measured fields.
RDF=Measured dose at a given field 
Measured dose at reference field                       (4)
RDF is  normalised to 1.000 at  reference  field [1,  42].  The RDF measurement  set-up and 
equipment is further described in Chapter III. 
In addition to the scatter originating within the patient's field, RDF accounts for any quantity 
that incorporates any detail  of the collimator exchange effect,  the backscatter  to the beam 
monitor chambers, and the scatter from irradiated structures of the head such as the flattening 
filter, the primary and secondary collimators, blocks, tray, MLC and beam compensator [50]. 
The CSF is also a measurable quantity at a reference depth but in air and with an appropriate  
build-up cap if  using  an  ion chamber.  CSF is  energy and field  size  dependant  [1] and a 
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quantity which has been introduced in order to calculate PSF [54]. PSF is not measurable and 
is deducted using equation (2); it is only dependant on the volume of the irradiated target at 
the reference depth for a given field size [1]. RDF is usually split into PSF and CSF and both 
factors  are  used  separately  for  MU  independent  verification  [30] and  quality  assurance 
purposes [30]. Some TPS such as ADAC and HELAX require entry of CSF, PSF and RDF 
separately [30] in which case both RDF and CSF have to be measured.
Dose delivery in MU in SRS needs to be achieved with an accuracy of 2% [24, 38]. The MU 
formula  (3)  shows  that  an  accurate  MU calculation  and  ultimately  an  optimal  SRS/SRT 
treatment  relies  first  on  accurate  measurements  of  all  the  components  involved  in  the 
algorithm  including  the  relative  dose  correction  factors,  RDF.  The  accuracy  of  the 
measurements of RDF relies primarily on the choice of the detector [38] used due to the size 
of the small fields involved in SRS. It is of a paramount importance that the measurements of 
RDF are right, accurate and verified before they are used; Entry of an inaccurate value during 
the commissioning of the TPS could affect a large number of treatment plans with a minimum 
chance that it is recovered
The measurements of RDF were initially carried out at WBRC as part of the commissioning 
of iPlan TPS. A number of water-proof detectors were used in the measurements in order to 
reach a maximum accuracy before the results were entered to run the iPlan TPS as well as  
tabulated for other clinical uses. In addition,  regular radiation fields were used, as per the 
manufacturer request, precisely, square m3 mMLC and square jaws fields were used [6]. 
During  treatment  planning,  irregular  m3  mMLC  fields  are  used  generated  by  the  TPS 
according to the shape of the lesion. The lesion has different shapes as seen and targeted from 
different angles. In this case, the RDF value to be used is looked-up by iPlan as the value 
measured  using  a  square  m3 mMLC field  of  the  same area  as  the  planned  irregular  m3 
mMLC. This is called the equivalent square concept. The equivalent square concept accounts 
for irregular fields as being regular as long as their areas are equivalent. In other words, the 
equivalent  square  concept  is  used  to  extrapolate  to  irregular  mMLC  fields  and  the 
corresponding RDF is selected by the TPS for MU calculation [47].
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Regular  MLC  fields  are  used  for  commissioning  purposes  and  in  most  physics  quality 
assurance routines but are not clinically relevant fields, the shape of the lesion to be treated is 
of a more complex shape and therefore the MLC field could only be irregular combined with a 
regular field set by the jaws. Furthermore, SRS fields of the same equivalent square could 
come under different shapes and also be encompassed by different sizes of fields set by the 
jaws. The importance of considering the fields' irregularity in dosimetry measurements relates 
to the physiological importance of every structure in the human brain. An optimal SRS/SRT 
treatment also depends on sparing the healthy tissue surrounding the lesion from any extra 
unwanted dose that could result in irreversible side-effects such as destroying the optic nerves 
or the brain-stem. 
In addition, WBRC uses the same jaws opening throughout a treatment plan, with iPlan as 
long as the field covers the largest m3 mMLC field, as part of WBRC procedural decision in 
Stereotactic  radiosurgery  treatment  planning  with  m3  mMLC  (BrainLAB,  Heimstetten, 
Germany). This reduces some of the related mechanical uncertainties to setting the jaws to a 
different position for every single m3 mMLC field. Reducing the treatment time is an other 
advantage for keeping the jaws at a fixed position.  
On the light of the described above, this research project aims at performing the measurements 
of  RDF correction  factors  using  irregular  m3 mMLC (BrainLAB,  Heimstetten,  Germany) 
fields  generated  using  iPlan  to  verify  the  equivalent  square  concept  adequacy  in  RDF 
measurements,  particularly.  In addition,  irregular  m3 mMLC fields of different shapes but 
same equivalent square were generated to measure RDF in order to investigate the influence 
of the shape only on RDF factors. In these cases, RDF were measured with respect to fields 
set by the jaws. The influence of the jaws opening on RDF was investigated, in other words, 
the influence of the mMLC-jaws margin width on RDF, in order to find the most appropriate 
jaws' field for a given m3 mMLC field. 
The measurements of RDF were performed using 2 sizes of small chambers, a stereo diode 
and the PRESAGE dosimeter. The following research questions were to be addressed:
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1. When  using  irregular  m3  mMLC  fields,  how  accurate  is  the  equivalent  square 
concept? And should RDF value be based on an average of measured RDFs from 
irregular m3 mMLC fields? and a number of irregular fields? 
2. How much influence has the shape of the irregular m3 mMLC field on the RDF? Or 
should “the shape” be considered in the measurement of RDF in the commissioning 
process?
3. By  examining  the  variation  of  RDF  with  respect  to  m3  mMLC  fields  and  jaws 
separately,  which collimation  component  has  the  largest  impact  on RDF? Could a 
protocol or a guideline be developed to refer to for the choice of jaws' field during 
treatment planning? 
Chapter II is a literature review giving a background about this research project starting on 
how the relationship  between “scatter”  and “scatter  factor”  was established back in 1970. 
Through a selection of important previously and recently undertaken research work in relation 
to  measurements  of  scatter  factors  in  the  field  of  SRS/SRT,  Chapter  II  underlines  the 
motivation behind this project. Both experimentally and non-experimentally RDF factors are 
being approached by researchers.  Most  of  the literature  is  commonly  comparative  studies 
relating to the detector types and sizes used to measure RDF, to the modalities used from 
linacs to tertiary collimators and more.   
In Chapter III, the material and methodologies used in undertaking this work were described. 
A 6 MV Novalis (Varian, CA, USA) linear accelerator photon beam was used with a built-in 
tertiary  collimator  device:  The  m3  mMLC  multileaf  collimator  (BrainLAB,  Heimstetten, 
Germany). iPlan was used to generate the m3 mMLC fields and four types of detectors were 
exposed for the measurements of RDF, a stereo diode, IC3 and IC13 ion chambers and the 
PRESAGE dosimeter. 
Chapter IV presents the results of the experiment. Measured RDF were compared to those of 
WBRC data, of regular fields. All correction factors variation were examined with respect to 
fields set by the jaws and fields set by the m3 mMLC. 
In Chapter V, the results are discussed with the related errors and uncertainties, and further 
work is suggested. 
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Finally a Conclusion is drawn, in Chapter VI, to whether the differences observed in RDF 
values  amongst  m3  mMLC  fields  of  the  same  equivalent  square  and  shapes  should  be 
considered in the measurements of RDF in the commissioning process or for quality assurance 
purposes. In addition, a conclusion is drawn to whether the PRESAGE dosimeter could be, so 
far, the detector of choice in small fields dosimetry in the context of Stereotactic treatments.
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  Chapter II
Literature Review
A large body of literature has addressed the efficacy of intra  and extracranial  stereotactic 
radiosurgery/radiotherapy. Stereotactic treatments deliver a large dose of up to 50 Gy [38] 
either in a single or fractionated radiation therapy in extremely conformal dose distributions to 
achieve a maximum dose to the target, while bringing as low as possible dose to the nearby 
healthy tissues and critical organs [3].
Stereotactic radiosurgery/radiotherapy involves the use of a linac with a collimation system 
that  has  a  physical  impact  on the  dose  reaching the  target  to  be  treated,  as  explained  in 
Chapter I. As shown in Figure II.1, that impact is inevitable and translated into the radiation 
beam hitting the various components of the collimation system and as a result, part of the 
radiation is scattered: 
           
Figure II.1: Scattered radiation path reaching a point of interest from different components of the linac. 
Reproduced from [20].
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The  scattered  dose  is  divided  into  scatter  originating  from  the  linac’s  head  and  scatter 
originating in the water phantom [1, 2]. 
Dose To The Target = Primary Dose + Scattered Dose           (1)  [1]
In addition, 
Scattered Dose = Scatter from the collimator + Scatter within the phantom   (5)
but, the mathematical and experimental relationship between “Scatter” and “Scatter factor” 
was  established  back  in  1970  [2].  In  1970,  Holt  et  al [2]  demonstrated  the  relationship 
between  “scatter”  and  “scatter  factor”  by  dividing  (1)  combined  with  (5)  by  the  dose  at 
reference field that is the field of the calibration of the linac. As a result, the following was 
obtained [2]: 
Dose to the target
Dose at Ref Field
=Primary Dose
Dose at Ref Field
Scatter from the collimator
Dose at Ref Field
Scatter within the phantom
Dose at Ref Field
    (6)
The three components of the dose are to be determined separately by measurements  [2] and 
the amount of scatter could be then graphically deducted. The equation (6) also represents the 
product of CSF x PSF as defined by equation (4) earlier and is the total radiation factor also 
co-noted RDF in different references including this thesis.
Many  research  projects  have  addressed  the  measurements  of  RDF,  in  the  context  of 
Stereotactic  treatments  both experimentally  and non-experimentally  such as  the studies of 
Ahnesjö et al, 2008 and Bassinet et al, 2013, [21, 28] respectively. In addition, RDF have also 
been  addressed  by  Francescon  et  al in  2008  using  both  methods  in  the  same  time  for 
comparison purposes [48]. This Chapter provides useful background knowledge to understand 
what stimulated and justified this project and relates how Stereotactic treatments delivery has 
been improving over the years on different levels and by introduction of different methods in 
the specific field of measuring the radiation scatter factors.
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II.1: RDF measurements
RDF is the total scatter correction factor defined as the dose at a reference depth in water for a 
given field size divided by the dose at the same point and depth in water for the reference 
jaws' field size of generally 10 x 10 cm2. RDF is field size dependent, [1].
RDF=Measured Dose in Water for a Given Field
Dose at Reference Field             (4)
Mathematically,                 RDF = CSF × PSF                               (3) 
Thus RDF contains both PSF and CSF and when divided by CSF yields the PSF. RDF has a 
maximum value  of  1.000  and  that  is  at  reference  field;  Although  small,  RDFs  are  non-
negligible components in the calculations of the dose to be delivered [38]. 
RDF are measured and tabulated during the commissioning of the treatment planning system 
(TPS) to correct for the dose to be delivered during the Stereotactic treatment. RDFs are also 
measured for quality assurance purposes [24,  13] and in very particular  circumstances  for 
investigating a monitor unit discrepancy. 
BrainLAB recommends  that  the  total  scatter  factors  are  measured  using  the  same linac's 
calibration setup, also known as reference-conditions: the doses must be measured at the same 
depth as the calibration depth as well  as the same SSD where the nominal linac output is 
measured. RDF is normalized with respect to field size of, generally, a jaw and m3 mMLC 
field size of 10 x 10 cm2 [6], also known as reference field [4, 42].
A formalism also exist on RDF measurements at other than reference field, known as relative 
field. This formalism introduces intermediate calibration fields that is either machine-specific 
reference  field  for  those  machines  with  no  conventional  reference  conditions  or  patient-
specific clinical fields [53].
Figure  II.2  shows  the  experimental  set-up  to  the  measurements  of  RDF  in  reference 
conditions. To this day, a significant number of publications, books and reports dealt with the 
RDF and all adopted the same experimental measurement set-up and definition of the total 
scatter factor [2, 1, 5, 22]1. 
1 Many more references can be mentioned here but we have limited the number to these four only.
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Figure II.2: Measurement set-up and reference conditions for RDF.
 Reproduced from [57].
RDF is a correction factor amongst other correction factors to be measured for the calculation 
of the dose in monitor units (MU) as expressed in formula (3) below. Thus, the accuracy of 
MU depends on the accuracy of the correction factors involved.
An  other  method  of  calculating  RDF  has  been  validated  by  Cheng  et  al [14]  using  an 
intermediate depth d and measured PDD(field, depth) and found to be accurate. The method 
however  does  maintain  the  validity  of  the  RDF  definition.  In  this  method,  RDF  is  first 
measured at depth d in water for a given field size A and calculated as shown in formula (7) 
using the PDD measurements for fields A and 10 x 10 mm2: 
RDF(A, dmax) = RDF(A,d)/(PDD(A,d) / PDD(10,d))      (7)
RDF(A, dmax) is the RDF at a maximum depth dmax, [14]. 
II.2: Monitor units
Monitor units (MU) denote the unit of measurement to quantify the prescribed dose in Gray 
(Gy) delivered by a linear accelerator [6]; it is measured through the linac's monitor chamber. 
A linac is calibrated to deliver a certain radiation dose amount per a given number of monitor 
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units, for example the Novalis (Varian, CA, USA) is calibrated to deliver 1Gy per 100 MU at 
reference depth of 5 cm [6]. A 1Gy per 100 MU calibration is a typical adjustment to a linac 
inner chamber electrometer circuit [38]. 
Monitor unit calculation is an important part of the Stereotactic treatment planning, in which 
the  prescribed  dose  to  be  delivered  to  a  patient  is  converted  to  MU for  each  individual 
radiation field to be used. In the case of BrainLAB, Pencil Beam is the algorithm used to 
convert the dose into MU through a Factor Formalism expressed in equation (3). The number 
of  monitor  units  is  independently  calculated  for  every  single  radiation  field  of  a  given 
treatment plan, [6].
MU=Prescribed Dose 
RDF x TPR x IDD x NLout x [ SSDcal + dcal / SSD + d ]2
        (3)
The factors in (3) are described in Chapter I. 
MU calculations are also performed manually for quality assurance (QA) purposes. Medical 
physicists  perform manual  dose  calculations  to  check  the  MUs  used  for  each  individual 
radiation field in a stereotactic treatment plan. The manual MUs calculations should agree 
with the TPS’s MUs within 2% for each field [BrainLAB user’s manual]. Such manual MU 
checks are done using simple dose calculation methods and are generally less accurate than an 
advanced TPS that uses more accurate dose calculation algorithms. However, a manual check 
does provide an independent validation of the MUs to prevent simple human mistakes during 
radiotherapy treatment planning and occasionally software errors in a TPS [35]. 
Due to the size of the lesions to treat in SRS/SRT and the biological importance of the brain, a 
quality assurance (QA) designed routine before an SRS/SRT treatment is an essential part of 
the treatment. The QA program must include an independent MU verification program [24].
II.3: Choice of detector
Radiation scattering inside a linac's head cannot be avoided from happening and reaching the 
target during radiotherapy treatments and hence can't  be dismissed in the dose calculation 
algorithm [38].
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Reliable measurements of scatter contribution to the target dose can only be made with a special type  
dosimeters which are sensitive to low doses and with small percentages of errors. Here interchangeably  
the terms dosimeter and detector terms are used through out this thesis.
There have been detailed discussions and recommendations for an optimal detector of choice 
to be employed in small field dosimetry. However, no particular detector has been selected to 
be the perfect one with clear levels of advantages over other ones.
 
Stereotactic RDFs for small fields are difficult to measure due to the size of the fields and the 
high dose to be delivered. Insufficient spatial resolution, tissue nonequivalence and loss of 
electronic equilibrium are the most common limitations of most small detectors [22, 7, 32]. 
Spatial resolution is defined as the allowance of the dosimeter to determine the dose from a 
very small volume, ideally a point referred to as “point dose” which must be well defined in a 
coordinate system [38, 40].
In addition, Sharma,  et al, 2007 [9] specified that the required appropriate dosimeter should 
have a  spatial  resolution of less than 1.0 mm and be water equivalent  to cause minimum 
interference with the radiation field [9]. 
Sharp dose gradients do require detectors or dosimeters with a high spatial resolution [6]. 
Ion chambers are the class of radiation detectors in which the radiation produces ionization 
events in a gas. The gas is contained in a chamber equipped with two electrodes which differ 
in electric potential by several hundred to typically thousand volts. Ion pairs formed by the 
incident  radiation  travel  to  the  positively  and negatively  charged electrodes;  the collected 
charges,  or  current,  is  measured  with  an  electrometer and considered  to  be the measured 
exposure under the external incident radiation [38]. For the measurements of RDF, BrainLAB 
recommends using an ionization chamber (maximum cavity volume of 0.125 cm3) for field 
sizes larger than 30 x 30 mm2 and a high-resolution detector such as a diode for field sizes up 
to 30 x 30 mm2 and a cross-calibration at 30 x 30 mm2 [6]. Figure II.3 shows a small ion 
chamber classically used in Stereotactic dosimetry, the IC3.
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Figure II.3: A type of ion chamber, the IC3, used in the measurements of RDF in this current project.
It is highly recommended that the ion chamber must be smaller than the smallest field in the 
range by at least 0.5 cm whether in diameter or in length in order to avoid chamber averaging 
effects and to fulfill the charge equilibrium condition upon which these chambers operate. The 
data should then be compared to data collected with a larger chamber for larger field sizes to 
see if the data overlap. It should also be noted that a small volume chamber may show some 
stem effect due to its cable irradiation when measuring the reference field of 10x10 cm2 [4, 
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Furthermore to the size of the chamber with respect to SRS/SRT fields, for fields diameters 
from 12.5 mm, a chamber of diameter  3.5 mm could achieve an accuracy of 0.5% in the 
measurements of RDF [1].
Stereotactic Field Diode, also referred to as SFD, is an unshielded, high resolution solid state 
detector constructed as shown in Figure II.4. SFD has an active volume of 1.7x10-5 cm3 and is 
specifically designed to measure small Stereotactic fields [39].
The Stereo diode is recommended by BrainLAB for small field dosimetry measurements [6]. 
It is recommended, for precise measurements of small-fields' dosimetry, that the diode should 
be x-rayed before use, at more than one rotational position to identify any construction and 
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symmetry related potential problems; and if necessary, the angular dose response should be 
measured to confirm any findings and consider how to take these into account [39].
Figure II.4: On the left is a diagram of the SFD showing the measurements, in mm, of the diode and on the right 
is the  x-ray image showing the silicon chip on top of the diode. Reproduced from [39].
A method of calculating RDF using diodes dose measurements is described by Kim et al, [3] 
but generally not recommended at large field sizes due to the over-response of small detectors. 
The method requires an additional RDF measurement using a small detector, a IC13 in this 
case, at an intermediate field, which is also the diode's reference field. The diode's final  RDF 
is then the product of IC13 RDF by the diode's “RDF” normalized at the intermediate field. 
The diode RDF is then given by: 
RDF=D  field   /D 30x30   xIC13 30x30   /IC13 100x100                     (8)
Where:
D(field) is the measured dose by the diode at a given field.
D(30×30) is the measured dose by the diode at the intermediate field size of 30x30 mm2.
IC13(30×30)/IC13(100×100) is the IC13 RDF measured for the 30×30 mm2 field size and 
normalized to the 100 ×100 mm2 field size.
PRESAGE is a relatively new dosimeter that was recently developed with some significantly 
advantageous  properties  for  small  field,  and  all  fields'  sizes  in  general,  3-dimensional 
dosimetry [19, 17]. PRESAGE is transparent, solid polyurethane based material, in which a 
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radiochromic  response occurs  following a  radiation  exposure  [17,  18];  it  is  similar  in  its 
operation to Gafchromic films but this one is 3 dimensional. 
The  dose  deposited  in  the  exposed  PRESAGE  is  read  out  using  an  optical  CT-scanner. 
PRESAGE represents  a practical  and convenient  tool  in  small  fields  dosimetry:  it  can be 
shaped into columns of precise dimension such as those shown in Figure II.5 or in relatively 
any needed size and shape and without external container, which makes it of great practicality 
and minimizes edge artifacts arising at the surface [17]. 
Furthermore, Guo et al, 2006 described the system PRESAGE-optical-CT scanner to be easy 
to implement, accurate, reliable, convenient and clinically viable. In addition, the system is 
able to acquire high-resolution 3D data sets that fully characterize a radiation dose distribution 
[18]. 
Figure II.5: PRESAGE dosimeters made in a shape of cylinders. From left to right, unexposed PRESAGE, fully 
exposed and finally partially exposed showing a touch of color in the middle of the cylinder. 
PRESAGE  is  well  suited  for  clinical  use  to  verify  modern  dose  delivery  techniques. 
PRESAGE is fluorescent light and normal laboratory environment temperature responsive. It 
needs to be kept in a freezer and protected from daylight UV. The radiochromic response is 
lower than 2% when irradiation temperature is stable and within 1 °C [17, 18]. 
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Several  studies  were  conducted  to  determine  the  PRESAGE full  potential  for  dosimetry. 
Water equivalency property of the PRESAGE dosimeter was investigated by  Gorjiara et al, 
2010 [15]. To be used as an ideal dosimeter for measurements in water such as measurements 
of RDF, the PRESAGE should be water equivalent. Three different PRESAGE formulations 
were used to assess their radiation dosimetry properties with their corresponding values for 
water [15].
Clift  et al,  2010 have highlighted the fundamental dosimetric advantages of PRESAGE for 
small-fields  3D  measurements.  This  includes  negligible  volume  averaging,  directional 
insensitivity, absence of beam perturbations, energy and dose rate independence [19].
The first application of combined PRESAGE and optical-CT 3D dosimetry system to small 
field commissioning was presented by Guo et al in 2006 [18] and in 2010, Clift et al, [19] 
investigated the same system for the acquisition of radiosurgery field of commissioning data 
from a Novalis Tx system with a high-definition multileaf collimator, the so called HDMLC. 
Clift et al measured the total scatter factors, beam profiles, and penumbrae for five different 
radiosurgery fields of 52, 102, 202, 302 and 402 mm2. Measurements of RDF performed with 
PRESAGE and films agreed with the ion chamber commissioning data to within 4% for each 
field [19].
TLD,  films,  Diamond  are  other  types  of  detectors  used  in  the  measurements  of  RDF in 
SRS/RST and small field dosimetry in general.  PRESAGE, Stereo diode and ion chambers 
were to be used in this project for the measurements of RDF.
Amongst  a  substantial  comparative  studies  looking for  the  detector  of  choice  to  measure 
Stereotactic small fields total scatter factors was the study of Calcina et al in 2007 [33]; An 
inter-comparison  of  dosimetric  parameters  was  performed  for  the  purpose  of  finding  the 
detector  of  choice  for  Stereotactic  small  radiation  fields.  The  fields  in  question,  small 
therapeutic x-ray beam field sizes, were described by the authors as comparable to or smaller 
than  the  build-up  thickness  of  1.5  cm  and  require  special  attention  to  avoid  incorrect 
interpretation  of  measurements  in  regions  of  high  gradients  and  regions  of  electronic 
disequilibrium. These occur at the edges of any collimated field, and can extend to the centre 
of the field if small enough. An inappropriate dosimeter can result in overestimation of dose 
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and possibly an overdose to the patient. Calcina  et al  used 6 MV photon beam on PMMA 
phantoms to measure lateral beam profiles, Percent Depth Doses (PDD), output factor and 
Tissue Maximum Ratio (TMR) for small fields of respectively 1, 3 and 5 cm2 for the squares 
and  10,  20  and  40  mm  diameter  for  the  circular  fields.  The  detectors'  responses  to  be 
compared  were:  a  thermoluminescent  dosimeter  (TLD),  Fricke  xylenol  gel  (FXG),  film 
dosimeters and a small ion chamber of 0.2 cc. The results demonstrated that high resolution 
FXG,  TLD and  film  dosimeters  agree  with  each  other  within  1% and  that  an  ionization 
chamber, with low spatial lateral resolution such as the 0.2 cc, underestimates the absorbed 
dose.  Moreover,  when dosimetric  measurements  across  a  small  field  are  made with  poor 
spatial resolution, the result will be a lower dose than the true value due to the volume of the 
detector.  This  could  potentially  lead  to  overdosing  the  patient.  However,  small  field 
radiotherapy cases do require dosimeters with appropriate lateral spatial resolution [33].
Some studies have compared scatter factors measured by different types of detectors.
 
Other comparative measurements looking for the detector of choice to measure total scatter 
factors for Stereotactic small fields were the measurements of RDF performed by [3] using 
shielded  and  unshielded  stereotactic  diodes  and  CC01  and  CC13  ion  chambers.  The 
measurements'  results confirmed the necessity of using small  detectors for small  fields,  as 
shown in Figure II.6. Figure II.6 shows a significant variation of the orders of 30% to 62% in 
the values of the total scatter factors for the smallest fields and a variation towards the same 
value for larger fields.
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Figure II.6: Total scatter factors measured using 2 types of diodes and 2 types of ion chambers. 
On the left are RDF measured with reference field of 30 x 30 mm2. On the right are RDF measured with 
reference field of 100 x 100 mm2. Reproduced from [3].
The unshielded stereotactic field diode (SFD) showed an overestimation of the dose by about 
2% for larger fields when the measurements are normalized to 100 x 100 mm2. SFD had also 
the sharpest profile penumbra due to its small active diameter of 0.6 mm. The ion chambers 
had  active  diameters  of  6  mm and  therefore  suffered  from volume  averaging,  [3].  Dose 
volume averaging in small detectors may result in a reduced detector signal, in which case the 
highest dose readings are likely to be the correct values. For this reason, the smallest detector 
should be used in small field dosimetry [59].
Chen et al, 2009 [25], on the other hand, compared RDF for 3 different small detectors with 
respect to beam energies of 4, 6 and 8 MV as shown in Figure II.7. 
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Figure II.7: RDF comparison with respect to beam energies of 4, 6 and 8 MV using 3 different detectors. 
Reproduced from [25].
The percent errors in RDF obtained from the three ionisation chambers for fields up to 5.0 x 
5.0  cm2 was  recorded  in  Table  II.1  below.  The  greatest  difference  is  observed  for  fields 
smaller than 3 x 3 cm2 due to the detector size [25].
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Table II.1:  Differences in RDF values between CC01 and CC13 and FC65, for all energies.
Reproduced from [25].
RDF, or output factors as referred to in the paper, were measured of BrainLAB cones using 
CC01, Pinpoint and parallel  plates ionization chambers, TLD-100 powder and Gafchromic 
MD-55-2  films  in  a  30  ×  30  ×  30  cm3 PMMA  phantom  [9].  The  measurements  were 
performed with square BrainLAB m3 mMLC fields and equivalent diameters of these square 
fields [9].
Figure II.8 shows the experimental data observed in the measurements of RDF using CC01, 
Pinpoint, Markus ionization chambers, films and TLDs. RDF from CC01 and the Pinpoint are 
in  excellent  agreement  for  all  the  cones.  RDF  from  TLD  and  radiochromic  film  are  in 
agreement with the ionization chambers RDF within 3% for all the cones. Finally comparing 
RDF from Markus chamber to the Pinpoint chamber for 7.5 and 10.0 mm diameter cones 
showed a 16.6 and 7.3% differences,  respectively.  These differences are unacceptable and 
therefore,  the  Markus  chamber  should  not  be  used  for  cones  smaller  than  12.5  mm.  In 
addition, Sharma  et al concluded that the mean of Pinpoint and Markus chamber measured 
RDF values for cones of diameter smaller than 12.5 mm should not be used for clinically [9]. 
33
Figure II.8: Comparison of RDF (output factors, St) with respect to different detectors as stated on the graph. 
Reproduced from [9].
In  a  much  more  specialised  study,  [32]  addressed  small-field  dosimetry  in  stereotactic 
radiosurgery (SRS) dosimetry focusing on electronic disequilibrium. Scatter correction factors 
were compared using two chambers of different sizes under the same measurement conditions 
and set-ups: a micro thimble and a so called JARP2 chamber of nominal ionization volumes 
0.009 ml and 0.600 ml respectively. Scatter correction factors were ways of understanding the 
behaviour of  secondary electrons  in  the  phantom as  well  as  in  the  collimator;  Secondary 
electrons are avoided in the measurements of collimator scatter factors but considered in the 
measurements of the total scatter factor. 
The study showed (Table II.2) a distinct decrease in scatter correction factors, from the micro 
to the JARP chamber, with decrease of field size smaller than 5 x 5 cm2 due to most secondary 
electrons generated by the collimator traveling far away from the exposed field.
In Table II.2, CSF, PSF and RDF are respectively referred to as Sc, Sp and St.
2 JARP stands for Japanese American Research Project. A JARP chamber is a Farmer ionization chamber of 
acrylic wall material [32]. 
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Finally,  the  authors  concluded  that  in  measurements  involving  electron  disequilibrium  a 
relative relationship between detector volume and field size should be considered. In addition, 
small field measurements should be performed using a micro-chamber [32].
Table II.2: Measurements results showing decrease in scatter correction factors, from the micro to the JARP 
chamber, with decrease of field size. Reproduced from [32].
Finally, Das et al. in 2000 used films, Diamond detector, cylindrical chambers, parallel plates 
chambers, TLDs, Laser densitometer and Monte Carlo simulation in order to generate dose 
profiles for small SRS fields and find the detector of choice for small field dosimetry [7]. Due 
to the large variations of detectors'  responses Das  et al. suggest new protocols must be in 
place for small field dosimetry and in the context of SRS/SRT in particular [7].
Two types of dosimeter were tested in this study; one active (clinical) –  ionisation chamber 
and the others passive such as diodes and PRESAGE gel dosimeters.
 
II.4: Structure of the linac
As explained in Chapter  I,  a radiation beam is collimated  by the Primary Collimator  and 
flattened  through the Flattening  Filter;  it  is  then monitored  by the Monitor  Chamber  and 
finally collimated with a pair of adjustable Jaws, and by a tertiary collimator, if necessary, 
such as an m3 mMLC before it exits the linac's head to reach the targeted phantom or patient 
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[38]. The dose to be delivered must consider all contributions adding to the primary dose from 
the source [1]. 
Figure II.1 shows, the scattering of the beam initially produced starting from the target and all 
the way through the collimation system of the linac to the phantom  [20]. The beam going 
through the linac’s head is scattered when hitting the surface of any component [38].
Experimentally, so far, separating the RDF into further scatter factors has not gone beyond 
quantifying it into phantom and collimator scatter factors; But the “collimator” scatter factor 
accounts for any scattering happening in the collimation system inside the linac's head.
Monte Carlo (MC) simulation code has proven to be a very strong tool in determining the 
contribution of each component in the collimator scatter factor and for example the modelling 
undergone by Zhu in 2002 [54]. Zhu [54] modeled the output factor in air3 and its impact on 
MU calculations  to show that MC method is a powerful tool for the quantification of the 
collimator scatter factor components. Using experiment and simulation, [54] further examined 
head scatter factor on 4 different linear accelerators for small fields, and found that the head 
scatter factor had 3 major components: source-obscuring effect, head-scatter and backscatter 
to monitor chamber. The head-scatter includes scatter from all parts of the linac’s head, with 
the majority from the flattening filter. The investigation with MC simulation proved to be 
useful in quantifying the magnitude of different component as shown in Figure II.9 [54]. In 
addition, the outcomes of this work helped develop a QA routine method for collimator scatter 
factor.
 
3 Often in the literature, the output factor in air is the collimator scatter factor, referring to the collimators as the 
most scattering parts [27]. 
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Figure II.9: MC results of the head scatter components contributions showing the highest contribution from the 
flattening filter. Reproduced from [54].
Comparing measured to simulated scatter factors using the Monte Carlo simulation code is 
being highly explored and reflected through the number of publications around it. It is steeply 
increasing over the years. Francescon et al, 2008 [48] demonstrated the validity of applying 
MC in the measurements of correction factors with small solid detectors that were found to be 
lower than 1.000 and consistent with previous studies. 
In 1994, [31] measured collimator scatter factors (called head scatter factors in their published 
paper) for opened small fields starting with a small field of 0.8 x 0.8 cm2. For intercomparison 
purposes  the  measurements  were  performed  with  and  without  the  flattening  filter  by 
delivering 200 MU using a 6MV photon Philips SL75-5 linear accelerator then repeating the 
same experiment on a Philips SL25, a VARIAN Clinac 600C and a VARIAN Clinac 1800 
accelerator. The experimental setup is shown in Figure II.10 with the components from right 
to left respectively are T as the target, PC as the primary collimator, F as the flattening filter, 
W as the wedge, XJ as the X jaws, YJ as the Y jaws, C as the collimator setting defined by 
field size and D the detector. The detector used is an ion chamber with a lead buildup cap at 5 
cm depth.
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Figure II.10: Experimental setup used by [31]. The set-up consists of a target (T), a primary collimator, (PC), a 
flattening filter (F), a wedge (W), the X jaws (XJ), the Y jaws (YJ), the collimator setting defined by field size 
(C) and the detector (D). Reproduced from [31].
Sharply reduced values of the head scattering were observed for fields smaller than 3 x 3 cm2 
for all accelerators. On the other hand, when the flattening filter was removed, only photons 
scattered from the movable collimator (jaws) and from the air contributed to the head scatter. 
The contribution was by less than 5%. However, when the flattening filter is put back in place, 
the head scatters showed a significant rise estimated to up to 8% at 10 x 10 cm2 field size.    
In 1995,  Ahnesjö [26] reported a MC model for investigating the scatter contributions from 
the linac’s head components to dose in the target volume. This MC model also showed that 
scatter from the flattening filter is the dominant contribution. The flattening filter is modeled 
as a sequence of truncated cones, thickest at its centre in the centre of the beam and behaves 
like an extended source distribution. This explains that most of the variation of beam output in 
air is due to variation of the field size. However, it makes it natural to assume that the primary 
photon fluence was highest at the centre of the filter and decreases towards the periphery. The 
scatter from the primary collimators accounted for less than 1% of the primary dose. 
The lack in models for collimator scatter in photon beam therapies proved more difficult than 
the experiment  to  identify  the cause of  variation  of  the ‘output  in  air’  from radiotherapy 
accelerators. The concerns are mainly related to output factors versus field sizes. The change 
in output with field size (the energy fluence per monitor unit) is often due to variation in 
scatter from the irradiated parts of the head/collimators. The MC investigation concludes that 
photon collimator scatter is not a dominant effect in radiation therapy with photon beams [26]. 
Ahnesjö, [26], also recommends that future considerations following this investigation should 
be to derive models simple enough to use in routine treatment planning QA. 
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In 1999, it was once again confirmed by Ahnesjo, [27] that the largest contributions of scatters 
originate  in the flattening filter  and close to the target  in the primary collimator.  But the 
magnitude and the relative importance of scatter from the various parts of the treatment head 
have often been a matter of confusion. Therefore, dose calculation methods for photon beams 
were reviewed in the context of radiotherapy treatment planning. The methods need to meet 
clinical  requirements  as  well  as  incorporate  detailed  modeling  of  scattered  dose  through 
implementation of measured data combined with various integration techniques [27].
As a significant amount of the therapeutic beam consists of scattered photons and secondary 
particles from irradiated components of the treatment head, handling of treatment head scatter 
was reviewed by Ahnesjo in 1999 [27]. The review provided new phase-space data for Monte 
Carlo based dose calculations.  The diagram in  Figure II.6  shows the steps  of  a  radiation 
photon beam towards becoming four components of dose deposited in the patient. (Refer to 
the four frames in the diagram): 
Figure II.11: Interaction history of the four dose categories commonly referred to in dose calculations for TPS: 
primary dose, dose from phantom scatter, dose from contaminant charged particle and dose from head scatter.
Reproduced from [27].
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Head scatter  sources are commonly classified into scatter  from the primary collimator  the 
flattening filter, collimator backscatter into the monitor and collimator scatter. For open (non-
collimated) beams on conventional machines, head scattered photons accounts for 1% of the 
total  energy  fluence  exiting  the  machine  [27].  Improper  filtering  of  charged  particle 
contamination affects output factors in air for high-energy beams and alters the output photon 
fluence to be inaccurate  [27].  The Monte Carlo calculations revealed how much the head 
scatter  sources  contributed  to  dose in  the targeted  volume:  less  than  3% (a configuration 
designed for a maximum beam diameter of 20 cm with a significantly thin and hence less 
scattering  flattening  filter  than  that  of  typical  clinical  machines)  while  experimentally 
determined these are found to reach 15% (with collimator trimmers very close to the monitor 
chamber causing an unusually high amount of monitor backscatter) [27]. 
Based on these simple findings and the relative importance of their magnitude, methods that 
model the dose from scattered particles were developed by Ahnesjo, 1999 [27].
II.5: Detector positioning
Dose delivery in SRS/SRT should be achieved as accurately as within 1mm of the isocentre 
[1, 38, 24, 52]. Therefore, the detector positioning is a very important part in the measurement 
of dose output in small fields  [25], the fields are small and the detectors are small so if the 
positioning is not accurate then so is the measurement. The construction of the detector is 
sometimes  very  important  to  know in  order  to  target  the  effective  point  of  measurement 
accurately and within the active volume of the detector.  For e.g. the stereo diode must be 
vertically positioned due the silicon chip location (Figure II.4) and a longitudinal positioning 
is needed for the ion chambers [39]. The PRESAGE for instance should be accurately marked 
before  positioning  in  order  to  meet  the  same  "point"  of  measurement  during  the  optical 
scanning.
As required by BrainLAB, 2011 amongst many more manufacturers and researchers, a special 
care is required when handling the required dosimetry devices. In small field dosimetry, it is 
particularly important to correctly align the water phantom and the detector axis to accurately 
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target the effective point of measurements with respect to the beam axis and the beam center. 
In addition, specifications provided by the detector manufacturer must be applied [6].
II.6: Shape of SRS/SRT small fields and the equivalent square concept
The definition of a small field in radiation dosimetry is currently very subjective and there is 
no clear definition to what is a small field. Commonly, however, a field size smaller than 3 x 3 
cm2 is  considered  outside  the  conventional  treatment  field  size  that  needs  particular  dose 
measurements as well as dose calculations. There are essentially three factors that determine 
whether a radiation field is small or not: the size of the beam source as projected from the 
detector location through the beam aperture, the size of the detector used in the measurements 
and the electron range in the irradiated medium. A more scientific criterion such as the beam 
energy and the density of the medium is believed to be needed to set the definition of a small 
field too [4].
The shape and irregularity of the fields in SRS/SRT is driven primarily by the shape of the 
lesion  to  be  treated.  It  is  slightly  modified  by  the  m3  mMLC  leaves  when  trying  to 
conformably out-contour the lesion due to the leaves' edge and width. The shape is certainly 
far from being square, rectangular or circular, it is irregular. As mentioned earlier in Chapter I, 
Stereotactic targets are small and have a typical volume of up to 35 cm3  that is a field size of a 
maximum of 5 x 5 cm2 at isocentre.
Until now, there are no guidelines on how to handle irregular MLC shaped fields, specifically, 
for independent monitor unit MU calculations [13].
Both, shape and size of the SRS/SRT fields have been addressed by many researchers in the 
determination and variation of scatter factors such as the studies of Georg et al in 2004 [13] 
and  Sharma et al in 2007 [9].
The equivalent square field is based on an integrating method [47] and defined in [8] as “that  
standard square field which has the same central axis depth dose characteristics as the non-
standard field”; it was also defined as the square field that has the same central-axis depth 
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dose characteristics as the non-square field. Later on, the equivalent square concept extended 
to other field size-dependent parameters, such as the total scatter factor [10].
MU calculations and measurements of dosimetric quantities using equivalent square fields is 
widespread and a well-established routine in radiation dosimetry [10]. Square m3 mMLC and 
square jaws fields were required by BrainLAB in the measurements to commission the pencil 
beam algorithm [6].
The most popular equivalent square formula in routine use for X and Y jaw settings is that of 
Worthley [10]:
Eq Sq= 2XY /(X + Y)                            (9)
Because this formula does not correct for the collimator exchange effect, for the collimator 
scatter factors particularly, the following empirical formula was proposed [10]:
Eq Sq= (A+1) XY / (AX + Y)                     (10)
where A is an empirical parameter to be determined.
Figure II.12 shows the measurements results by Thomas et al in 2008 of RDF for square and 
rectangular fields [10]. The graph shows clearly the difference in RDF for both type of fields' 
geometry. In addition, it was shown the collimator exchange effect (the dots) [10].
Equation (10) was found to, particularly, underestimate the phantom scatter factor for fields 
where  one  side  is  too  small  to  ensure  lateral  electronic  equilibrium  happening.  In  2008, 
Thomas et al. proposed the following formula to model for this effect [10]:
Eq Sq= (B+1)(XminXmax/(BXmin + Xmax)                          (11)
Where,
B is an empirical parameter to be determined, Xmin  and Xmax  are the smaller and larger field 
dimensions,  respectively.  The  formula  was  found to  have  a  great  value  in  monitor  units 
verification programs in small fields radiotherapy [10].
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Figure II.12: Total scatter factor (Spc in the Y axis) for square and rectangular fields.
 The line represents measured data for square fields. The 2 series of points represent measured data for 
rectangular fields showing the collimator exchange effect, as expected, when X and Y are interchanged. 
Reproduced from [10].
In clinical practice for fields of irregular shapes, the collimator scatter factor will still “equal  
that for the jaw position” but for the phantom scatter factor a new version of the equivalent 
square formula was implemented in which “the average of each leaf separation is used” [10]. 
For the collimator scatter factor, Kim et al in 1998 defined the equivalent field as the field that 
produces the same ratio of collimator scatter to primary dose on the central axis as the field in 
question [47]. 
In  an  irregular  field,  the  scatter  contribution  from a  tertiary  collimator  was  found  to  be 
dependent on the area perpendicular to the beam axis as well as the area of the side wall on the 
field edge. The scatter contribution from both areas should be treated independently [47].
The shape of the radiation fields was also addressed in the determination of scatter factors. 
Sharma et al, 2007 measured RDF for equivalent “circle” fields defined by their diameters as 
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shown in Figure II.13. The Equivalent diameter was used for square m3 mMLC fields using 
their equivalent circle in order to be compared to circular BrailnLAB and Radionics SRS/SRT 
cones [9].
Figure II.13: Comparison of output factors (RDF) of different radiosurgery collimators measured using Pinpoint 
ionization chamber. Reproduced from [9].
Figure II.13 reveals that RDF of BrainLAB and Radionics circular cones are close to each 
other within 2% for all diameters. This slight variation in RDF of the SRS circular cones may 
be  due  to  the  difference  in  the  physical  dimensions  and  material  used  by  the  two 
manufacturers.  Figure II.7  also shows a large difference  between RDF for  BrainLAB m3 
mMLC defined  equivalent  diameter  fields  RDF  for  corresponding  BrainLAB  cones;  this 
difference is field size dependent and decreases with increasing field diameter. The difference 
in RDF of the two BrainLAB SRS systems was found to be between 3 and 15%. A reason for  
such a large difference,  although from the same manufacturer,  could be explained by the 
material type and design of the two systems as well as high leakage from the m3 mMLC [9].
Furthermore  to  equivalent  fields  method,  equivalent  diameters  of  elliptical  fields  were 
established as a new consensus in 2004, using a number of methods and achieved with an 
accuracy of 0.5% [11].
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Figure II.14: Irregular MLC shapes used in the study of Georg et al measure and calculate phantom and scatter 
factors. Reproduced from [13]
In 2004, Georg  et al looked at irregular MLC fields through collimator scatter factors and 
phantom scatter factors separately whereas in this project irregular m3 mMLC fields were 
used to investigate total scatter factors, RDF [13]. Georg et al compared different approaches 
for independent MU verification, to determine collimator scatter factors and phantom scatter 
factors for irregular MLC shaped fields. A total of ten MLC field shapes, shown in Figure 
II.14  were  generated  using  five  different  MLCs'  manufacturers:  Elekta,  Siemens,  Varian, 
Scanditronix,  General  Electric.  Different  beam  energies  were  used  as  well  as  different 
chambers.  Measured and calculated  scatter  factors  using  equivalent  square  methods,  were 
compared. For highly irregular fields, PSF deviations were greater than 5%. This result was 
not  acceptable  for  PSF  calculations  and  therefore,  the  equivalent  square  method  is  not 
recommended in this case. For measured and calculated CSF however, the equivalent square 
approach resulted in a better result and a deviation smaller than 3%.
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Georg et al strongly recommended to separate PSF and CSF to achieve an accuracy of better 
than 1.5% in independent MU calculation in most conformal radiotherapy cases [13].
For irregular  MLC shaped beams, the collimator  scatter  and phantom scatter  factors  have 
different factors of influence.  For example,  a study by Das  et al in 2008 [4] showed that 
modifying the beam shape with a multileaf collimator changes the contribution from scattered 
photons originating in the treatment head only.
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Chapter III
Materials and Methods 
This chapter describes the materials and methods used in this project. 
Combined facilities from WBRC, The Alfred and RMIT Applied Science were used in this 
project. A Novalis (Varian, CA, USA) linear accelerator, a BrainLAB m3 mMLC (BrainLAB, 
Heimstetten, Germany), BrainSCAN iPlan TPS, IC3 ion chamber, IC13 ion chamber, a stereo 
diode, a Perspex mini phantom and an electrometer were used at WBRC. From RMIT, the 
PRESAGE dosimeter and the optical CT-scanner were provided.
RDF were measured for various irregular and asymmetric scatter conditions shapes and sizes 
of the m3 mMLC and square jaws fields using a number of detectors.  The measurements 
process is described below and so is the material used.
The following were taken into consideration in the measurements of RDF; they define the 
conditions and frame in which the measurements were performed:
• Reference field size was set by the jaws opened to 9.8 x 9.8 cm2  and m3 mMLC by 10 
x 10 cm2 for the ion chambers and the PRESAGE but 30 x 30 mm2 for the stereo 
diode.
• Novalis (Varian, CA, USA) linac has been calibrated to deliver 2 Gy per 200 MU with 
an estimated relative calibration error of 2% for a 10 x 10 cm2 field, at reference depth 
of 5 cm in water and SSD of 95 cm. 
• Some of m3 mMLC fields of the different shapes and same equivalent square areas 
were generated with a 0.1 x 0.1 mm2 difference. 
• Measurements of RDF are only taken for fields where jaws openings are larger than 
the m3 mMLC openings.
• Up to 5 readings were taken for each measurement field to reduce the error margin.
• The  measurement  set-ups  were  repeated  as  well  as  the  measurement  sets  for  all 
detectors in order to reduce the detectors' positioning related uncertainties. 
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III.1: Materials
III.1.1: Novalis  Linac  
Figure III.1 shows the gantry of the 6 MV Novalis (Varian, CA, USA) linac of WBRC used in 
the measurements of RDF.
Figure III.1: WBRC 6 MV Novalis (Varian, CA, USA) linac of WBRC used in the measurements of RDF. The 
linac is dedicated to Stereotactic treatments.
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III.1.2: BrainLAB m3 micro multileaf collimator
The BrainLAB micro multileaf collimator also known as m3 mMLC (BrainLAB, Heimstetten, 
Germany)  shown in  Figure  III.2  is  the  newest  generation  of  tertiary  collimator  designed 
specifically for Stereotactic treatments [46]. The effective beam penumbra is of < 3.0 mm for 
all SRS field sizes and irregularly shaped target volumes.
Figure III.2: BrainLAB m3 mMLC (BrainLAB, Heimstetten, Germany) cover and window aperture of WBRC.
Over the total  field size of 10 × 10 cm2, the m3 mMLC consists of 26 pairs of leaves of 
variable width at isocentre: 14 pairs of 0.3 cm, 6 pairs of 0.45 cm, and 6 pairs of 0.55 cm of 
leaves.  The  leaves  are  made  of  an  18  g  cm−3 tungsten  alloy  with  95% tungsten  and are 
independently driven by individual motors and computer-controlled from a remote location 
[46]. The m3 mMLC has a depth of 6 cm. The radiation leakage and transmission from all the 
interleaves for a field set by the jaws of 9.8 x 9.8cm2 was estimated at  1.1 % during the 
commissioning of iPlan in WBRC.
III.1.3: BrainSCAN Treatment Planning System, iPlan RT Dose 4.5
 iPlan RT Dose version 4.5 BrainSCAN TPS was used to generate the m3 mMLC fields and 
calculate iplan RDF. The TPS runs using one of the two major algorithms, Pencil beam and 
Monte  Carlo.  Pencil  beam algorithm  was  selected  through  out  this  project.  Pencil  beam 
algorithm is a method to calculate dose distributions in radiotherapy in which the radiation 
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beam is divided into beamlets [6]. The dose calculation matrix resolution was set to 0.75mm 
for the smaller m3 mMLC sizes and 1.5mm for the rest.
One  of  the  advanced  performances  of  iPlan  is  the  automatic  calculation  of  m3  mMLC 
equivalent square for any given mMLC shape. This has been a big advantage in generating the 
mMLC fields for this project. Figure III.3 shows one of the m3 mMLC fields used in this 
project with an equivalent square of 17.5 x 17.5 mm2 calculated by iPlan. 
Figure III.3: A snapshot of one of the ten irregular m3 mMLC fields generated using iPlan. 
III.1.4: Ionisation chambers
From the Technical Certificate of the WELLHOFER IC3 and IC13 [44, 45], the chambers are 
waterproof and have, respectively, active lengths of 3.3 mm 5.8 mm and volumes of 0.03 cc 
and 0.13 cc [WELLHOFER, 1995]. Both chambers are shown in Figure III.4.
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Figure III.4: From left to right, WELLHOFER IC13 and IC3 Ion Chambers and stereo diode used at WBRC for 
small fields dosimetry. 
III.1.5: Stereo Diode
Shown in Figure III.4. The stereo diode, namely SPF is a water-proof detector manufactured 
by IBA Dosimetry and designed for measurements in small photon beams. SPF was to be 
positioned parallel to the beam central axis with the top surface at isocentre, i.e. reference 
depth of 5 cm.  
III.1.6: PRESAGE Dosimeter 
The water equivalent PRESAGE dosimeter was first prepared in the Chemistry Department of 
The University of Melbourne under the supervision of Dr Alqathami. In specific proportions, 
the  ingredients  in  the  preparation  of  the  PRESAGE  were:  The  commercially  available 
diisocyanate  known as Part A, polyol known as Part B, leuco malachite green, Chloroform 
CHC13 and DBTDL as a catalyst. The mixture was vigorously and quickly stirred in the dark 
then poured inside the plastic cuvettes shown in Figure III.5. The cuvettes were then put for 
about 48h under dry pressure to compress any unwanted air bubbles or humidity that changes 
the composition of the PRESAGE. The cuvettes are parallelepiped and have a dimension of 1 
x 1 x 4.5 cm. All the PRESAGE to be used in the measurements was prepared in a single  
batch for consistency reason.
51
Figure III.5: Cuvettes of the prepared PRESAGE to be used in the measurements. 
The cuvettes measure 1 x 1 x 4.5 cm.
Once the PRESAGE was ready, it was immediately wrapped in a dark cling film and put in 
the freezer under about -18oC until it was used in the measurements of RDF.
III.1.7: Optical CT-Scanner
Figure III.6: The optical CT-scanner with the PRESAGE cuvette being placed inside for an optical CT-scanning 
read-out.
Figure III.6 shows a UV-1800 SHIMADZU spectrophotometer more commonly called optical 
CT  scanner.  This  scanner  is  designed  to  read  out  PRESAGE  cuvettes  only.  Once  the 
PRESAGE is exposed, it is either scanned immediately or kept in the freezer for later optical 
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Cuvette goes here
CT-scanning. A calibration is first performed using an unexposed PRESAGE cuvette, ideally 
from  the  same  cuvette  batch  which  is  the  case  in  this  project,  and  the  “zero”  dose  is 
determined as it appears in a red line in Figure III.7 below. The cuvette is placed inside the 
scanner open box on the left as shown in Figure III.6. The read out takes place in the middle  
point of the cube centimetre located at 1 cm above the base of the cuvette.
Figure III.7: A snapshot from the optical CT-scanner software system showing a read-out of a scanned 
PRESAGE cuvettes being placed inside the optical CT-scanner.
III.1.8: Perspex Mini Water Phantom 
The mini phantom is a Perspex phantom manufactured at WBRC, shown in Figure III.8. The 
mini-phantom measures 15 x 15 cm2 in inner surface and 17.2 cm in depth. 
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Figure III.8: RDF measurement set up showing the IC3 chamber in the mini phantom at 5 cm depth in water. 
The room lasers' were used to accurately position the chambers, the PRESAGE and the stereo diode at isocentre. 
III.1.9: Dose 1  Electrometer  
Dose 1 electrometer was manufactured by iba-dosimetry and was used in this project to record 
the measurements' readings. The detectors were connected to the electrometer placed at the 
linac console with a cable that goes through the radiation shielding wall. 
Dose 1 displayed the readings with an uncertainty margin of  ±0.005 nC and has a  Serial 
Number of 15384.
The electrometer conversion factor was not applied to convert the displayed reading into dose 
in Gy because the purpose of the measurements was to calculate RDF that are ratios of two 
readings and the conversion factors would have been cancelled.
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Figure III.9: Dose 1 electrometer used in the measurements of RDF. 
III.2: Methods 
III.2.1: Generating the m3 mMLC fields
Using images  of  a  scanned water  phantom with  a  specified  isocentre  at  5  cm depth,  ten 
irregular m3 mMLC fields were generated using iPlan RT Dose 4.5 in order to measure RDF. 
The shape of the fields  were entirely arbitrary  and the equivalent  square areas  of the m3 
mMLC fields’ were calculated and given by iPlan and are recorded in Table III.1. In addition, 
those mMLC fields were, each, generated again under two other different shapes but same 
equivalent areas. 
The square m3 mMLC fields that were used in the measurements were from m3 shape files 
already saved by the physicists at WBRC during their routine clinical quality assurance work.
The jaws at this stage were not set to the measurements position as shown in Table III.1 below 
but were in an arbitrary position.
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Square m3 mMLC 
fields areas (mm2)
Irregular m3 mMLC equivalent
 square Areas (mm2) Jaws sides (mm)
12.0 x 12.0 12.3 x 12.3 2513.0 x 13.0 30
18.0 x 18.0 15.0 x 15.0 3517.5 x 17.5 40
24.0 x 24.0 20.5 x 20.5 4524.8 x 24.8 50
28.0 x 28.0 28.1 x 28.1 6033.0 x 33.0 70
36.0 x 36.0 39.4 x 39.4 8045.3 x 45.3 90
Table III.1: m3 mMLC and jaws fields areas used in the measurements of RDF. 
III.2.2: Measurements of RDF
Once, the m3 mMLC fields were generated, they were then transferred to the linac's console. 
The measurements set up is shown in Figure III.8. The lateral and sagittal lasers used during 
treatments to position the patient were used to carefully and accurately position the chambers, 
diode and the PRESAGE at mechanical isocentre and reference depth of 5 cm. In order to 
reduce the positioning related errors, the measurements were repeated for each detector with a 
new set-up on a different day. 
In order to further verify the depth of 5 cm in water, the SSD, SAD and the alignment of all 
detectors,  the  linac's  cross-hairs  were  used  and  the  optical  distance  indicator  (ODI)  was 
switched on. The alignment using the cross-hairs and ODI was crucial in the alignment of the 
diode particularly as it  had to be aligned with the top surface at  isocentre,  parallel  to the 
central beam axis. 
The couch and the gantry angles were both at 0o. The collimator was rotated to 90o in order to 
have the mMLC leaves perpendicular to the chamber’s axis. 200 MUs were delivered for all 
fields. RDF were calculated using equation (4) in Chapter I. 
For practical reasons however, the jaws were set to the same size for all m3 mMLC fields 
during the planning with iPlan; they were then manually changed to the desired size at the 
linac’s console during the measurements. 
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For the stereo diode, measurements were performed using an intermediate reference field of 
30 x 30 mm2. RDF was then the product of IC3 RDF for 30 x 30 mm2 by the diode's “RDF” 
normalized at the intermediate field. The diode RDF for a given mMLC field was calculated 
using equation (8) in Chapter II but replacing the IC13 by IC3 instead and that is: 
 
RDF (Diode) = RDF (IC3, 30 x 30 mm2) x (diode measured dose for a given mMLC / diode 
measured dose for mMLC of  30 x 30 mm2)
The measurements using the diode and the IC3 were performed simultaneously on the same 
day for consistency reasons.
Before the measurements with the PRESAGE were performed, the cuvettes were first marked 
to where the isocentre should be, that is the centre of the middle part (a cube of 1 x 1 x 1 cm 3) 
which is also the reading point of the optical scanner. At room temperature and in the dark, the 
cuvettes were positioned inside the mini phantom in a way that the cuvette is parallel to the 
beam axis and has its open top facing up toward the linac's target. Each cuvette was exposed 
once  only  and  due  to  the  known  response  of  the  PRESAGE  dosimeter  under  different 
temperatures, the cuvettes were immediately returned to the freezer following the exposure 
where the temperature was about -18 oC.
Following the instructions provided in the optical CT manual [56], the optical density (OD) 
was first evaluated in the unexposed cuvettes to determine the “zero” value, the calibration of 
the  PRESAGE in  other  words.  The  exposed  cuvettes  were  then  scanned  and  RDF were 
calculated using equation (4) in Chapter I. In this case where we were calculating ratios, the 
conversion  of  OD into  dose  deposited  was  not  necessary  since  RDF was  a  ratio  of  two 
readings of different fields. Each cuvette was scanned 3 times and each time it was removed 
and  put  back  into  its  slot  before  the  scanning  also  to  reduce  any  positioning  related 
uncertainties.
Finally, to calculate RDF using iPlan, first, 2 Gy were prescribed to all fields individually with 
the corresponding jaws. The corresponding MU was then calculated by iPlan and RDFs were 
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manually calculated by dividing the calculated MU by 200. 200 MU corresponds to the 2 Gy 




In this chapter, the following aspects were considered:
1. All measurements were normalised to the specified fields of 98 x 98 mm2 for IC3 and 
IC13 and 30 x 30 mm2 for the stereo diode.
2. All measurement points in the graphs were RDF calculated from measured raw data.
3. All measurement points in the graphs were join by a line for easy visual tracking.
4. In  all  the  graphs  no  smoothing  or  best-fit  to  the  curves  was  applied  in  order  to 
accurately show the influence of the fields irregularity and detector/dosimeter size on 
the results. 
5. The error bars were not shown on the graphs due to the number of series/curves in 
each graph which could lead to mixing up of the data and hence to confusion. The 
uncertainties related to all data were separately discussed.
6. The figures' legends appear showing the side of the equivalent square in mm of the 
jaws or m3 mMLC field in question.
IV.1: RDF measurements
IV.1.1: RDF Measurements using IC3 
Figures IV.1 and IV.2 show the variation of the measured RDF using the IC3 with respect to 
fields set by the jaws and by the irregular m3 mMLC, respectively. The variation in Figure 
IV.1 shows a maximum increase of 2.02% in RDF with increasing jaws' fields and that is for 
mMLC of 12.3 x 12.3 mm2. The increase is more pronounced for jaws range beyond 60 x 60 
mm2. 
In Figure IV.2 a much more pronounced RDF increase is observed with the increasing mMLC 
areas, in particular for the smallest range and in the same time the series close to each other 
confirm the results in Figures IV.1.
Figure IV.1 shows less points of measurements for larger m3 mMLC fields due to the fact that 
the jaws opening must be larger than the mMLC field.
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Figure IV.1: IC3 RDF vs jaws for each m3 mMLC field represented in the graph by each series. 
Figure IV.2: IC3 RDF vs mMLC for each jaw opening represented in the graph by each series.
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IV.1.2: RDF Measurements using IC13
Figures IV.3 and IV.4 show, the variation of the measured RDF using the IC13 with respect to 
fields set by the jaws and by the irregular m3 mMLC, respectively. The variation in Figure 
IV.3 shows a constant RDF with the increasing openings of the jaws, compared to Figure 
IV.1. The difference was expected due to the size of the detectors. 
In Figure IV.4 a much more pronounced RDF increase with the mMLC is shown for the 
smallest range. In addition, the constant variation of RDF with the jaws' opening is confirmed 
through the superposition of the series in Figure IV.4.
Figure IV.3 shows less points of measurements for larger mMLC fields due to the fact that the 
jaw must be larger than the mMLC field.
Figure IV.3: IC13 RDF vs jaws for each mMLC field represented in the graph by each series.
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Figure IV.4: IC13 RDF vs mMLC for each jaw opening represented in the graph by each series.
 
IV.1.3: RDF Measurements using the Stereo Diode
Figures IV.5 and IV.6 show, the variation of the measured RDF using the diode with respect  
to fields set by the jaws and by the smallest irregular m3 mMLC, respectively. Due to the size  
of the diode, only four m3 mMLC fields and four jaws openings were used and investigated. 
For this range of fields, the variation in Figure IV.5 shows a steeper increase of RDF with the 
increasing fields of jaws, compared to Figure IV.1 for IC3 as expected due to the size of the 
diode being smaller than the IC3. In addition, a larger gap between RDF values is shown as 
compared to Figure IV.1.
In Figure IV.6 a steeper RDF than in Figure IV.2 for IC3 is shown with increasing mMLC 
fields, as expected due to the size of the diode. 
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Figure IV.5: Diode RDF vs mMLC for each jaw opening represented in the graph by each series.
Figure IV.6: Diode RDF vs jaws for each mMLC field represented in the graph by each series.
IV.1.4: RDF calculations using iPlan RT Dose 4.5 
Figures IV.7 and IV.8 show the variation of the calculated RDF with respect to jaws and m3 
mMLC openings, respectively, using iPlan RT Dose 4.5. RDF show a maximum increase of 
0.22% only with respect to jaws smaller than 50 x 50 mm2 as shown in Figure IV.7, for larger 
jaws RDFs are clearly constant. These results are further confirmed in  Figure IV.8.
Figure IV.7 shows less calculation points for larger mMLC fields due to the fact that the jaw 
must be larger than the mMLC field.
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Figure IV.7: iPlan calculated RDF vs jaws for each mMLC field represented in the graph by each series.
Figure IV.8: iPlan calculated RDF vs mMLC for each jaw opening represented in the graph by each series.
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IV.2: RDF comparisons of measurements
IV.2.1: Percent difference between RDF measured with IC3 and IC13 
Table  IV.1  shows  the  percent  differences  in  RDF  between  IC3  and  IC13.  The  highest 
differences are observed for the smallest m3 mMLC fields due to the size of the IC13 being 
too large as stated earlier in the chapter.  
     m3(mm)
jaws 
(mm)
12.3 13.0 15.0 17.5 20.5 24.8 28.1 33.0 39.4 45.3
25 -1.6 -1.2
30 -1.7 -1.3
35 -1.7 -1.2 -0.8 0.0 0.2
40 -1.8 -1.3 -0.8 -0.1 0.1
45 -2.0 -1.5 -0,9 -0.2 0.0 0.2
50 -1.9 -1.5 -0.7 -0.1 -0.1 0.2
60 -1.9 -1.2 -0.8 0.0 0.2 0.2 0.3
70 -2.3 -1.7 -1.2 -0.3 -0.1 0.1 0.2 0.2 0.1
80 -2.6 -2.1 -1.5 -0.7 -0.5 -0.2 -0.2 -0.1 -0.1
90 -3.0 -2.3 -1.8 -0.9 -0.9 -0.4 -0.4 -0.3 -0.2
Table IV.1: % differences between RDF measured with IC3 and IC13.
Jaws and m3 sides are in mm. 
IV.2.2: Percent difference between RDF measured with IC3 and the stereo diode 
Table IV.2 shows the differences in RDF between IC3 and the diode. The highest percentage 
is observed for the m3 mMLC field of 13.0 mm eq sq side. The best agreements in RDF 
between both detectors is for the smallest m3 mMLC field of 12.3 mm eq sq side. This could 
well be due to the size of the diode being too big for fields equal and larger than 13.0 x 13.0  
mm2. 
       m3(mm)
jaws
(mm)
12.3 13.0 15.0 17.5
25 0.3 1.7 1.2 1.3
30 0.1 1.9 1.3 1.5
35 0.2 2.0 1.5 1.6
40 0.5 2.3 1.7 1.9
Table IV.2: % difference between RDF measured with IC3 and the stereo diode. 
Jaws and m3 sides in mm.
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IV.2.3: Percent difference between RDF measured with IC3 and iPlan calculations
Table IV.3 shows the percent differences between measured and calculated RDF with the IC3 
and iPlan respectively. The highest difference observed is of 2.8 % and for two fields only so 
further comparison was done of iPlan RDF with IC13 and discussed in the Results chapter.
     m3(mm)
jaws 
(mm)
12.3 13.0 15.0 17.5 20.5 24.8 28.1 33.0 39.4 45.3
25 0.2 -0.2 -0.5
30 0.1 -0.4 -0.7 -0.1 -0.8
35 0.2 -0.3 -0.6 -0.1 -0.6 -0.7
40 0.3 -0.2 -0.5 0.0 -0.4 -0.2
45 0.4 -0.1 -0.4 0.2 -0.2 0.2
50 -0.1 -0.3 -0.5 0.2 0.0 -1.9
60 0.0 -0.2 -0.3 0.3 0.0 -1.8 -2.8 -0.5
70 -0.5 -0.6 -0.7 -0.1 -0.2 0.2 0.2 0.2 0.1 0.1
80 -0.6 -1.0 -1.0 -0.4 -0.6 -0.2 -1.0 -1.8 -0.1 -0.1
90 -1.6 -1.4 -1.4 -0.9 -1.0 -2.8 -0.4 -0.3
Table IV.3: % difference between RDF measured with IC3 and iPlan calculations.
Jaws and m3 sides are in mm. 
IV.3: RDF comparisons for square m3 mMLC fields and different detectors
Figure IV.9 shows the difference in RDF for square m3 mMLC fields using IC3 and IC13. A 
difference of 3.75 % is observed between the series of curves. RDFs are larger for the IC3, in 
the smallest mMLC range of up to 24 eq sq side (mm), once again, due to the detector size 
effect. 
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Figure IV.9: IC3 and IC13 measured RDF series for all jaws openings and square mMLC fields showing a 3.75 
% difference for the smallest range of mMLC fields. 
Figure IV.10 shows the difference in RDF for square mMLC fields using IC3 and the diode. A 
maximum difference of 1.91 % is observed between two series of same jaws showing a larger 
RDF for the diode in the smallest mMLC range which also confirms the detector size effect.
Figure IV.10 also shows that for mMLC fields larger than 17.0 mm eq sq side, RDF measured 
with IC3 are larger than those measured with the diode and this also confirms the detector size 
effect; In this case the diode is too small for RDF measurements of larger mMLC fields.
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Figure IV.10:  IC3 and the diode measured RDF series for all jaws openings and square mMLC fields showing a 
1.91 % difference for the smallest range of mMLC fields. 
IV.4: RDF comparison of measurements using irregular m3 mMLC to RDF 
using square m3 mMLC fields
Figure IV.11 shows the difference in RDF measured for square and irregular m3 mMLC fields 
using the IC3. For the smallest range of mMLC of up to 15.3 mm eq sq side, RDF show no 



























Figure IV.11: IC3 measured RDF series for all jaws openings showing a difference gap between square and 
irregular m3 mMLC fields RDF of up to 0.24 % only.
Figure IV.12 below shows the difference in RDFs measured for square and irregular mMLC 
fields using the IC13. The maximum difference is estimated to 1.33 %.
Figure IV.12: IC13 measured RDF series for all jaws openings showing the difference gap between square and 
irregular m3 mMLC fields RDF of up to 1.33 %.
69




























































Figure IV.13 shows the difference in RDF measured for square and irregular mMLC fields 
using the stereo diode. The figure shows that RDF for irregular mMLC are higher than those 
of square mMLC fields by an overall 1.18% except for fields larger than 18 mm eq sq side.
Figure IV.13: Diode measured RDF series for all jaws openings showing the difference between square and 
irregular mMLC fields of up to 1.18%. 
Having shown that there exists a difference between RDF measured with square m3 mMLC 
and  RDF  measured  with  irregular  m3  mMLC  fields,  more  irregular  mMLC  fields  were 
manually generated of the same equivalent squares but of different irregular shapes, using 
iPlan, in order to investigate further the mMLC “shape” factor in the measurements of RDF. 
RDF were measured for these fields and compared in the following paragraphs.
IV.5: RDF comparison of measurements for individual m3 mMLC fields of 
same equivalent squares and different shapes
IV.5.1: Using IC3
Figure IV.14 shows measured RDF of three m3 mMLC fields of 12.3 x 12.3 mm2 but of 
different irregular shapes, using IC3. Each curve in the figure represents one particular shape 
of the irregular mMLC. The difference observed in RDFs is between 0.1 and 3.1 amongst all 
jaws fields.
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Figure IV.14: IC3 measured RDF for 3 different shapes of irregular m3 mMLC field of 12.3 x 12.3 mm2.
The min % difference is 0.1 and the max is 3.1 amongst all jaws fields. 
Figure IV.15 shows measured RDF of three mMLC fields of 13.0 x 13.0 mm2 but of different 
shapes, using IC3. Each curve in the figure represents one particular shape of the irregular 
mMLC. A difference of up to 4.7% is observed in RDF for a 13.0 x 13.0 mm2 mMLC field 
between the different shapes.
Figure IV.15: IC3 measured RDF for 3 different shapes of irregular m3 mMLC field of 13.0 x 13.0 mm2.
The min % difference is 0.04 and the max is 4.7 amongst all jaws fields. 
Figure IV.16 shows measured  RDF of  three mMLC of  15.0 x 15.0 mm2 but  of  different 
shapes, using IC3. Each curve in the figure represents one particular shape of the irregular 
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mMLC. A difference of up to 2.7% is observed in RDF for a 15.0 x 15.0 mm2 mMLC field 
between the different shapes.
Figure IV.16: IC3 measured RDF for 3 different shapes of irregular m3 mMLC field of 15.0 x 15.0 mm2.
The min difference is 0.1 % and the max is 2.7 % amongst all jaws fields. 
IV.5.2: Using IC13
Figure IV.17 and IV.18 show, respectively, measured RDF of three m3 mMLC fields of 20.5 
x 20.5 mm2 and 24.8 x 24.8 mm2 but of different shapes, using IC13. In each graph, each 
curve represents one particular shape of the irregular mMLC. The max difference observed in 
RDF is 0.9 % and 0.6 % for 20.5 x 20.5 mm2 and 24.8 x 24.8 mm2 respectively, amongst all 
jaws fields. 
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Figure IV.17: IC13 measured RDF for 3 different shapes of irregular m3 mMLC field of 20.5 x 20.5 mm2.
The min difference is 0.1 % and the max is 0.9 % amongst all jaws fields. 
Figure IV.18: IC13 measured RDF for 3 different shapes of irregular m3 mMLC field of 24.8 x 24.8 mm2.
The min difference is 0.01 % and the max is 0.6 % amongst all jaws fields. 
IV.5.3: Using the stereo diode
Figure IV.19 and IV.20 show, respectively, measured RDF of three m3 mMLC fields of 12.3 
x 12.3 mm2 and 13.0 x 13.0 mm2 but of different shapes, using the diode. In each graph, each 
curve represents one particular shape of the irregular mMLC. A difference of up to 3.2% in 
observed in RDF for a 13.0 x 13.0 mm2 mMLC field between the different shapes.
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Figure IV.19: Diode measured RDF for 3 different shapes of irregular m3 mMLC field of 12.3 x 12.3 mm2.
The min difference is 0.0 % and the max is 2.9 % amongst all jaws fields. 
Figure IV.20: Diode measured RDF for 3 different shapes of irregular m3 mMLC field of 13.0 x 13.0 mm2.
The min difference is 0.1 % and the max is 3.2 % amongst all jaws fields. 
IV.5.4: Using iPlan RT Dose 4.5
Figures IV.21 and IV.22 show, respectively, calculated RDF of three m3 mMLC fields of 12.3 
x 12.3 mm2 and 17.5 x 17.5 mm2 but of different shapes, using iPlan. In each graph, each 
curve represents one particular shape of the irregular mMLC. A difference of up to 1.7% in 
observed in RDF for a 12.3 x 12.3 mm2 mMLC field between the different shapes.
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Figure IV.21: iPlan calculated RDF for 3 different shapes of irregular m3 mMLC field of 12.3 x 12.3 mm2. 
The min difference is 0.3 % and the max is 1.7 % amongst all jaws fields. 
Figure IV.22: iPlan calculated RDF for 3 different shapes of irregular m3 mMLC field of 17.5 x 17.5 mm2.
The min % difference is 0.04 and the max is 0.3 amongst all jaws fields. 
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IV.5.5: Using the PRESAGE dosimeter
In order to further support the results for the smallest mMLC fields, RDF were measured with 
the PRESAGE dosimeter for 2 different shapes of mMLC fields of 12.3 x 12.3 mm2 and 15.0 
x 15.0 mm2 with jaws of  25 x 25 mm2 and 30 x 30 mm2 respectively.  The results  were 
compared to RDF measured with IC3, the stereo diode and iPlan as shown in Table IV.4. 
Table IV.4 shows the PRESAGE RDF in better agreement with the diode's RDF. 
Table IV.4: % difference between PRESAGE RDF and RDF measured with the IC3, diode and iPlan 
calculations for 2 pairs of mMLC fields. Each pair of fields has the same equivalent square areas but different 
shape.
Finally, PRESAGE RDF for the two mMLC were compared with respect to the shapes only 
and a maximum of 2.5 % difference was observed for the RDF values as shown in Table IV.5.
Table IV.5: % difference between RDF measured with the PRESAGE for 2 pairs of mMLC fields. Each pair of 
fields has the same equivalent square area but different irregular shape.
IV.6: Results related uncertainties
To the best possible, uncertainties in RDF measurements were brought to lower than 1.5% 
accuracy by considering 1) on the electrometer, up to 5 readings for each measurements, 2) all 
detectors  positioning errors  reduced through the  repeat  of  the measurement  setup and re-
measurements,  3) the PRESAGE cuvettes were all  from the preparation batch and kept as 
instruction  in  relation  to  temperature  and  day  light  and,  4)  the  PRESAGE  readout  was 
repeated  at  least  3  times  on  the  optical  CT  in  order  to  meet  accurately  the  point  of 
measurements.
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 m3 mMLC(mm) jaw side(mm) ic3 diode iplan
12.3 25 2.1 0.4 1.4
12.3 25 1.4 1.6 1.4
15.0 30 1.3 1.0 2.2
15.0 30 0.5 0.7 0.0
Chapter V
Discussion
Stereotactic Radiosurgery/Radiotherapy methods are reliable in delivering a relatively high 
radiation  dose to  small  lesions  of  about  35 cm3 [40]  and the maximum radiation  field in 
SRS/SRT is of  50 x 50 mm2 at SSD of 100 cm. In order to achieve an optimal stereotactic 
treatment, a special care is required when handling the dosimetric measurements to calculate 
the final dose, in MU, to be delivered. This includes the choice of the appropriate detector, its 
size, its type and its positioning in the treatment field.
As described in Chapter I, the calculated MU to be delivered from a linac for a SRS/SRT is 
given by: 
    MU=Prescribed Dose 
RDF x TPR x IDD x NLout x [ SSDcal + dcal / SSD + d ]2
   ((3) Chapter I)
The Prescribed Dose (Gy) to a target needs to be accurately corrected to become the dose in 
MU to be delivered from the linac. One of the correction factors is the relative dose factor, 
RDF, also called the total scatter factor, measured in this project.
Measurements  of  RDF  were  carried  out  in  this  project  in  order  to  address  the  research 
questions in Chapter I and evidence was provided through the Results chapter that not only 
RDFs respond to  mMLC and jaws setting  but  also  to  the  shape  of  the  radiation  field  in 
question even if the area stays the same; This response in turn, is related to the type of detector 
used to measure RDFs.
Using iPlan,  ten  m3 mMLC fields  were  manually  generated  to  mimic  realistic  shapes  of 
tumours to be treated.  The results have shown normalised RDF all  smaller than 1.000, as 
expected  at  least  for  regular  square  mMLC  fields.  In  addition,  all  RDF  increased  with 
increasing mMLC field sizes for all  detectors  used.  With respect to jaws, RDF were also 
found to increase with the increasing jaws opening relatively to the size of the detector used in 
the  measurements.  For  example,  in  Figures  IV.3,  IV.1  and  IV.5  the  increase  in  RDFs 
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gradually from IC13 to IC3 to diode was clearly due to different detectors used, respectively. 
RDFs went from constant values for all jaws using the IC13 to 0.54% increase for jaws up to 
40 x 40 mm2 using the IC3 to finally RDFs increased by 1.12% using the stereo diode also for 
jaws up to  40 x 40 mm2.  This  result  is  consistent  with many studies  that  found that  the 
smallest detector is to be used in small fields dosimetry such as the study of [3] and [32] and 
many others; but these studies however used regular MLC fields instead to investigate the 
detector size for RDFs, such as square or circular MLC fields whereas in this project totally 
irregular mMLC were used. Further to this result, for different given mMLC shapes and  jaws 
up to 40 x 40 mm2 , IC3 and diode's RDF results showed, respectively, an increase by up to 
1.15 % (Figure IV.16) and by up to 3.89 % (Figure IV.19). 
Our results, so far, suggest that IC13, being larger in volume than both IC3 and the diode, was 
most likely too big and might not be suitable for small SRS fields measurements. In addition, 
jaws changing during treatment planing should be considered for a given mMLC field, at least 
for jaws smaller and/or equal to 40 x 40 mm2.
Figures  IV.9  and  IV.10  comparing  RDF  measured  for  square  mMLC  fields  have  also 
confirmed the detector size effect by showing higher RDF value for smaller detectors but for 
the smallest mMLC fields.
 
In addition to the differences observed in RDF due to detector sizes and types, differences 
were  also  observed  in  RDF  due  to  mMLC shapes  only.  Although  the  equivalent  square 
mMLC areas were the same, RDF were different only because the shape of the fields were 
different. This is also consistent with the results found in the studies by Thomas et al, 2008 
[10],  Sharma et  al,  2007 [9] and Georg et  al,  2004 [13] that  investigated  the relationship 
between irregular MLC fields and scatter  factors. In our case though, the irregular mMLC 
fields were generated in an asymmetric scatter conditions, therefore, each time the mMLC 
leaves change positions, the scatter contribution changes resulting in a different RDF. RDF 
difference  could  be  as  significant  as  3.2  %  (Figures  IV.20)  and  4.7  %  (Figures  IV.15) 
observed in the case of the diode and IC3 respectively for mMLC eq sq side of 13.0 mm.
The m3 mMLC is the final aperture in the collimation system that the beam goes through 
before reaching the detector or the patient, so the radiation field, as seen in the BEV, takes 
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necessarily the shape of the mMLC aperture. Each mMLC field amongst those of same eq sq 
and different shapes has its own view to the linac's internal head and therefore has its own 
scatter origins configuration. As demonstrated using Monte Carlo simulation, each component 
in the linac's head has its own contribution to the total scatter factor [29, 58] and depending on 
what the mMLC's view is, the RDF is valued accordingly.
In comparing RDFs for square mMLC to irregular mMLC, Figures IV.11, IV.12 and IV.13 
show respectively RDF measured using IC3, IC13 and the diode with 0.24 %, 1.33 % 1.18 % 
differences, respectively. Consequently, our results showed that differences observed in RDF 
for square and irregular mMLC fields are within the accuracy of 1.5% for all our detectors, 
therefore the equivalent square concept was verified and found to be valid in this case. Since a 
significant  difference was observed earlier  amongst RDF for irregular mMLC of different 
shapes and same eq sq, it  could be that more comparisons should be done for square and 
irregular mMLC to draw a final conclusion about the equivalent square concept. 
Calculated RDF values using iPlan, however, were found to be constant for fields larger than 
50 x 50 mm2 and increasing by a negligible amount of 0.2 % for jaws below 50 x 50 mm2 
(Figure IV.7). These RDF were an average of measured RDF using all of IC3, IC13, stereo 
diode and micro TLDs for the commissioning of iPlan in WBRC using square m3 mMLC. It  
might be that the RDF from the IC13 have been the dominant ones so constant RDF were 
observed for all jaws. Therefore, using iPlan, the same jaws throughout a treatment plan and 
delivery should be acceptable and used. On the other hand, and in some cases, such as the case 
of WBRC practice, the same jaws opening are used throughout a treatment plan and delivery 
in order to reduce the mechanical related uncertainties when changing the jaws every time a 
beam changes. Further more, due to the leakage and radiation transmission observed during 
the measurements  of  the dose for  the  same mMLC field  and changing jaws,  a  minimum 
margin should be kept between mMLC and jaws edges; but again this could not be possible all 
around the target due to the irregularity of the mMLC field. Only 1.1 % leakage was measured 
through a closed m3 mMLC and fully  opened jaws during the commissioning of  the m3 
mMLC.
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Furthermore to iPlan related results, the differences observed in iPlan RDF in Figures IV.21 
and IV.22 of a maximum of 1.7 % also confirmed that iPlan RDF values were not mMLC 
shapes dependant.
Finally, in order to further endorse the results for irregular mMLC RDF as well as reach a 
better  accuracy  in  our  investigation,  the  PRESAGE  dosimeter  was  used  and  showed  a 
difference of up to 2.5 % in RDF due to the mMLC field shape change, Table IV.5. Due to the 





SRT/SRS involves complex dosimetry consideration due to the size of the fields also due to 
lack of protocols for small fields dosimetry in general [4]. The measurements' set-up needs to 
be of precision and the detector needs to be of choice. 
This project measured and calculated RDF using a range of detectors for clinically relevant 
irregular  m3 mMLC fields.  In addition,  each mlc field was associated  with a set  of jaws 
openings. All measurements in this project are measured many times and the averages with 
statistically acceptable values are employed for each type of dosimeter used. 
The results were compared to RDF for irregular fields of the same equivalent square areas as 
well as square mMLC fields. The differences were up to 4 % amongst the same detector used 
for a range of mMLC fields. This difference is larger than the measuring systems accuracy.
Regular mMLC fields with symmetric scatter conditions are widely used and accepted in the 
radiotherapy world. Regular mMLC fields were also used in the measurements of RDF for the 
commissioning  of  the  m3 mMLC at  WBRC.  This  project  has  shown that  the  method  of 
measuring  RDF could  well  be  beyond just  averaging the  results  from different  detectors' 
readings in order to use them clinically. The shape of the radiation fields is an other factor of 
influence on the RDF values and should be considered in the measurements of RDF. Square 
and circular mMLC fields, for example, are far from being clinical treatment fields, so it may 
be appropriate to consider averaging RDF for irregular clinical fields.
The addressed research questions stated in Chapter I led to the following conclusions:
• The equivalent square concept was validated for a range of irregular m3 mMLC fields 
only and where the measurements' accuracy is better than the uncertainty margin, so 
the equivalent square concept could not be used as a general approach.
• The same jaws opening throughout a treatment plan and delivery is only valid beyond 
a specific m3 mMLC field sizes range.
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• Irregular  m3 mMLC fields  should be considered in  the measurements  of  RDF for 
commissioning  purposes  and  not  necessarily  be  averaged  from  different  mMLC 
irregular shapes as we will suggest.
In  the  case  where  we  don't  average  between  shapes,  it  is  worth  investigating  whether  a 
protocol should be in place on how to bench mark an irregular mMLC field and create  a 
library. The protocol should identify the shape “type” of an mMLC field by where it fits best 
into a known regular shape such as square, rectangle, elliptical or circular mMLC shape. On 
that base, an equivalent “shape” is applied and a corresponding RDF is selected. 
In conclusion this research confirms that usage of the field equivalency for irregularly shaped 
fields formed by an m3 mMLC introduces significant effects into the dosimetery. Also this 
work  showed  that  the  opening  of  the  jaws  in  the  case  of  employing  an  m3 mMLC has 
significant effects on the dose outputs. 
In  addition,  this  project  could  well  stimulate  further  work  in  the  same  field  of  RDF 
measurements  for irregular  m3 mMLC stereotactic  fields.  Some of the work could be the 
Monte Carlo modelling of the measurements of RDF in order to obtain “detector independent” 
RDF and therefore different references and parameters are considered.
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